These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 17350735

  • 1. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR, Letvin NL.
    Vaccine; 2007 May 10; 25(19):3731-41. PubMed ID: 17350735
    [Abstract] [Full Text] [Related]

  • 2. Optimization and delivery of plasmid DNA for vaccination.
    Jechlinger W.
    Expert Rev Vaccines; 2006 Dec 10; 5(6):803-25. PubMed ID: 17184219
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant.
    Zhang L, Widera G, Rabussay D.
    Bioelectrochemistry; 2004 Jun 10; 63(1-2):369-73. PubMed ID: 15110305
    [Abstract] [Full Text] [Related]

  • 4. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.
    J Virol Methods; 2008 Nov 10; 153(2):142-8. PubMed ID: 18722475
    [Abstract] [Full Text] [Related]

  • 5. DNA vaccines--challenges in delivery.
    Pachuk CJ, McCallus DE, Weiner DB, Satishchandran C.
    Curr Opin Mol Ther; 2000 Apr 10; 2(2):188-98. PubMed ID: 11249641
    [Abstract] [Full Text] [Related]

  • 6. Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy.
    Minigo G, Scholzen A, Tang CK, Hanley JC, Kalkanidis M, Pietersz GA, Apostolopoulos V, Plebanski M.
    Vaccine; 2007 Jan 26; 25(7):1316-27. PubMed ID: 17052812
    [Abstract] [Full Text] [Related]

  • 7. Microparticles and nanoparticles as delivery systems for DNA vaccines.
    Cui Z, Mumper RJ.
    Crit Rev Ther Drug Carrier Syst; 2003 Jan 26; 20(2-3):103-37. PubMed ID: 14584521
    [Abstract] [Full Text] [Related]

  • 8. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
    O'Hagan DT, Singh M, Dong C, Ugozzoli M, Berger K, Glazer E, Selby M, Wininger M, Ng P, Crawford K, Paliard X, Coates S, Houghton M.
    Vaccine; 2004 Dec 16; 23(5):672-80. PubMed ID: 15542189
    [Abstract] [Full Text] [Related]

  • 9. Strategies for improved formulation and delivery of DNA vaccines to veterinary target species.
    van Drunen Littel-van den Hurk S, Babiuk SL, Babiuk LA.
    Immunol Rev; 2004 Jun 16; 199():113-25. PubMed ID: 15233730
    [Abstract] [Full Text] [Related]

  • 10. Synthetic vehicles for DNA vaccination.
    van den Berg JH, Nuijen B, Schumacher TN, Haanen JB, Storm G, Beijnen JH, Hennink WE.
    J Drug Target; 2010 Jan 16; 18(1):1-14. PubMed ID: 19814658
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.
    Bellier B, Dalba C, Clerc B, Desjardins D, Drury R, Cosset FL, Collins M, Klatzmann D.
    Vaccine; 2006 Mar 24; 24(14):2643-55. PubMed ID: 16481074
    [Abstract] [Full Text] [Related]

  • 12. Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development.
    Goh SL, Murthy N, Xu M, Fréchet JM.
    Bioconjug Chem; 2004 Mar 24; 15(3):467-74. PubMed ID: 15149173
    [Abstract] [Full Text] [Related]

  • 13. Surface modified liposomes for nasal delivery of DNA vaccine.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A, Vyas SP.
    Vaccine; 2008 Apr 24; 26(18):2225-33. PubMed ID: 18396362
    [Abstract] [Full Text] [Related]

  • 14. DNA vaccines: a role for liposomes.
    Gregoriadis G.
    Curr Opin Mol Ther; 1999 Feb 24; 1(1):39-42. PubMed ID: 11249682
    [Abstract] [Full Text] [Related]

  • 15. Intradermal naked plasmid DNA immunization: mechanisms of action.
    Elnekave M, Furmanov K, Hovav AH.
    Expert Rev Vaccines; 2011 Aug 24; 10(8):1169-82. PubMed ID: 21854310
    [Abstract] [Full Text] [Related]

  • 16. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice.
    Wang KY, Guo YJ, Zhang YL, Lv K, Sun SH.
    Vaccine; 2007 May 30; 25(22):4429-36. PubMed ID: 17420075
    [Abstract] [Full Text] [Related]

  • 17. DNA vaccines for biodefence.
    Garmory HS, Perkins SD, Phillpotts RJ, Titball RW.
    Adv Drug Deliv Rev; 2005 Jun 17; 57(9):1343-61. PubMed ID: 15935877
    [Abstract] [Full Text] [Related]

  • 18. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 19. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W, Ren L, Jin N.
    J Virol Methods; 2007 Dec 16; 146(1-2):266-73. PubMed ID: 17868910
    [Abstract] [Full Text] [Related]

  • 20. Engineering of DNA vaccines using molecular adjuvant plasmids.
    Sin JI, Kim J, Chattergoon M, Ayyavoo V, McCallus D, Ugen KE, Boyer JD, Weiner DB.
    Dev Biol (Basel); 2000 Dec 16; 104():187-98. PubMed ID: 11713819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.